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Introduction
Dynamic control of the actin cytoskeleton is essential for cell 
polarization, migration, and division (Evangelista et al., 2003; 
Pollard and Borisy, 2003). Proper actin remodeling involves the 
activation of different eukaryotic nucleation factors that can 
generate specifi  c types of new actin fi  laments. The actin-related 
protein 2/3 (Arp2/3) complex nucleates new actin fi  laments 
while remaining anchored to the sides of existing fi  laments, 
  creating branched actin networks (Higgs and Pollard, 2001). 
  Formin proteins nucleate unbranched fi  laments, creating actin 
cables, contractile rings, and stress fi  bers (Evangelista et al., 
2002; Sagot et al., 2002; Sharpless and Harris, 2002; Zigmond, 
2004). Although the Arp2/3 complex is known to play impor-
tant roles in processes such as cell polarization, motility, and 
vesicle traffi  cking, much less is know about the biological func-
tions of formins, especially in higher eukaryotes. Similarly, al-
though molecular regulation of the Arp2/3 complex by upstream 
signals is understood in some detail (Higgs and Pollard, 2001), 
much less is known about the regulation and function of the 
much larger formin family.
The formins are defi  ned by a conserved C-terminal formin 
homology (FH) 2 domain that mediates effects on actin (Wallar 
and Alberts, 2003; Watanabe and Higashida, 2004; Zigmond, 
2004; Higgs, 2005; Higgs and Peterson, 2005). The FH2 do-
main functions as a dimer and has varying effects in different 
formins, including actin fi  lament nucleation, fi  lament severing, 
and barbed-end binding with elongation (anticapping effect) or 
without elongation (capping effect; Evangelista et al., 2002; 
Kovar et al., 2003; Li and Higgs, 2003; Pring et al., 2003; Harris 
et al., 2004; Romero et al., 2004; Xu et al., 2004).
The function of the conserved N-terminal region found in 
most formins is still unclear. In vitro and in vivo studies with 
mouse diaphanous 1 (mDia1) have demonstrated a role for its 
N terminus in mediating the autoinhibition of FH2 activity (see 
the following paragraph; Watanabe et al., 1999; Alberts, 2001; 
Ishizaki et al., 2001; Li and Higgs, 2003, 2005). Other studies 
with the fungal formins Bni1p, Fus1, and SepA have implicated 
their N termini in regulating localization in vivo (Petersen et al., 
1998; Ozaki-Kuroda et al., 2001; Sharpless and Harris, 2002). 
For both Bni1p and Fus1, perturbation of cellular localization 
disrupts biological activity (Petersen et al., 1998; Ozaki-Kuroda 
et al., 2001). It is unclear whether the effects of the N terminus 
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on FH2 activity and cellular localization are linked or whether 
the N terminus simply serves different roles in different formins. 
Elucidating the general regulation of formin localization and 
activity in higher eukaryotes is important for understanding the 
biological activities of these molecules.
In the diaphanous-related formin (DRF) subfamily of 
formins, a short ( 20 residue) conserved region called the 
  diaphanous autoregulatory domain (DAD) follows the FH2 
  domain in sequence (Alberts, 2001; Higgs and Peterson, 2005). 
In mDia1, the DAD binds to the N terminus to inhibit the actin 
assembly activity of the FH2 domain through an unknown 
mechanism (Alberts, 2001; Li and Higgs, 2003). The DAD-
binding element in the N terminus is called the diaphanous 
  inhibitory domain (DID; Li and Higgs, 2005). Rho binds to the 
mDia1   N terminus through a region that spans a portion of the 
DID and an adjacent sequence element termed the G region (for 
GTPase binding; Otomo et al., 2005; Rose et al., 2005). Rho 
binding destabilizes interactions between the N and C termini, 
leading to partial activation of the mDia1 FH2 domain  (Watanabe 
et al., 1999; Li and Higgs, 2003). The mDia1 N terminus forms 
a dimer through its dimerization domain (DD) and coiled coil 
(CC) region (Otomo et al., 2005; Rose et al., 2005). Based on 
sequence similarity, the G-DID-DD-CC architecture of the 
mDia1 N terminus is likely to hold for other DRF family members 
(Higgs, 2005). The formin FHOD1 is also likely to be auto-
inhibited based on cytoskeletal effects of mutant proteins stud-
ied in vivo (Koka et al., 2003). However, the generality of FH2 
domain autoinhibition through a DAD–DID interaction and 
  activation by Rho GTPases has yet to be established directly for 
DRFs other than mDia1.
FRLα (formin-related gene in leukocytes α) is a 
  macrophage-enriched DRF whose FH2 domain can nucleate 
new actin fi   laments and sever existing fi   laments in vitro 
(Yayoshi-Yamamoto et al., 2000; Harris et al., 2004). FRLα has 
been reported to bind to Rac and modulate cell adhesion, migra-
tion, and survival, but its molecular function in macrophages 
has not been explored in detail (Yayoshi-Yamamoto et al., 
2000). Because of its unique expression profi  le, we hypothe-
sized that understanding FRLα may reveal new aspects of for-
min biology in higher eukaryotes as well as elucidate general 
principles governing the biological and biochemical regulation 
of formin proteins.
We fi nd that the FRLα N terminus binds to the C terminus 
in a DAD-dependent manner and inhibits the actin assembly 
  activity of the FH2 domain. For both FRLα and mDia1, autoin-
hibition also regulates a previously unrecognized plasma mem-
brane localization activity of the N-terminal domains. This 
activity has both GTPase-dependent and -independent compo-
nents. For FRLα, active Cdc42 relieves the autoinhibition of 
FH2 activity in vitro and membrane localization activity in 
macrophages. Knockdown experiments reveal that FRLα is re-
quired for effi  cient Fc-γ receptor–mediated phagocytosis, which 
is consistent with its role as a macrophage-enriched Cdc42 
  effector. Live cell imaging shows that FRLα is transiently re-
cruited to the phagocytic cup in a Cdc42-dependent manner. 
These studies reveal a general mechanism of DRF regulation 
in which autoinhibition controls actin assembly activity and 
  cellular localization. In addition, we identify a new biological 
function for DRFs in the immune system of higher eukaryotes.
Results
Autoinhibition regulates the actin 
assembly activity and intracellular 
localization of FRL𝗂
Most previous in vivo studies of DRF N-terminus function have 
used fragments based on GTPase-binding domain (GBD)–FH3 
sequence elements (Yayoshi-Yamamoto et al., 2000; Kato 
et al., 2001). However, recent structural studies of the mDia1 
N terminus have demonstrated that these sequence elements 
do not demarcate structural elements of the protein. Therefore, 
the results from previous studies using constructs representing 
divided structural domains are diffi  cult to interpret (Yayoshi-
Yamamoto et al., 2000; Kato et al., 2001). In this study, we have 
used predicted structural domains of FRLα based on sequence 
alignments with mDia1 to examine the function of its N- and 
C-terminal domains (Otomo et al., 2005). Our N-terminal con-
struct (residues 1–450) contains the regions of FRLα that align 
with the G, DID, and DD elements of mDia1 (FRLα appears to 
lack a CC region), whereas our C-terminal construct (residues 
612–1,094) contains the FH2 and DAD domains (Fig. 1 A). 
Pull-down assays show that the immobilized GST-tagged N 
terminus can interact directly with the untagged C terminus 
(Fig. 1 B). Binding is also observed when immobilized   maltose-
binding protein (MBP)–tagged C terminus is used to pull down 
GST-tagged N terminus (Fig. 1 C). The DAD motif is required 
for binding because a C-terminal construct mutated at a con-
served leucine residue within the DAD motif (L1062D) can-
not interact with the N-terminal fragment (Fig. 1, B and C). 
Mutation of the same residue in mDia1 (unpublished data) or 
mDia2 (Alberts, 2001) also prevents interactions between N- and 
C-terminal fragments.
As previously described, the FH2 domain of FRLα can 
stimulate actin fi  lament assembly, although it is  50-fold less 
potent than the FH2 domain of mDia1 (Fig. 1 D; Li and Higgs, 
2003; Harris et al., 2004). The N terminus inhibits the activity 
of the C terminus in a dose-dependent manner with an IC50 of 
 100 nM (Fig. 1 E) but has no effect on the L1062D DAD mu-
tant or FH2-independent actin assembly (Fig. 1, D and F). Thus, 
the biochemical activity of the FRLα FH2 domain is regulated 
by high affi  nity DAD-mediated autoinhibitory interactions with 
the N terminus.
We transfected RAW 264.7 cells, a mouse macrophage 
cell line, with GFP-tagged FRLα. Full-length FRLα is cyto-
plasmic and is excluded from the nucleus, as shown by confocal 
images of cells coexpressing FRLα-GFP and monomeric RFP 
(mRFP), a uniformly distributed fl  uorescent control (Fig. 2 A). 
In contrast, the N-terminal fragment of FRLα is located pri-
marily at the plasma membrane, suggesting that in the full-length 
protein, the cellular localization of the N terminus may be con-
trolled by binding to the C terminus (Fig. 2 B). To test this hy-
pothesis, we determined the cellular localization of FRLα-GFP 
proteins with mutations that would impair the N + C  interaction. 
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membrane localization of full-length FRLα (Fig. 2 C). In 
mDia1, an L260E mutation in the N-terminal DID region blocks 
DAD binding without affecting Rho interactions (Otomo et al., 
2005). The analogous mutation in full-length FRLα (V281E) 
causes the protein to localize at the plasma membrane (Fig. 2 D). 
Quantitation of the ratio of GFP fl  uorescence intensity at the 
plasma membrane to the intensity in the cytosol shows that all 
membrane-localized FRLα constructs exhibit 2–4.5-fold en-
richment at the plasma membrane, whereas cytosolic FRLα 
constructs have a ratio near 1 (Fig. 2 F). The degree of enrich-
ment is largely independent of the overall expression level for 
all constructs shown here (Fig. 2 F).
To test whether interactions between the N terminus and 
DAD are suffi  cient to mediate the control of FRLα cellular 
  localization, we constructed a truncated FRLα protein called 
mini-FRLα, which lacks the FH2 domain. Mini-FRLα contains 
the G, DID, and DD regions tethered by a (Gly-Gly-Ser)2 linker 
to the DAD-containing C-terminal 101 residues (Fig. 1 A). 
When purifi   ed from overexpressing bacteria, this protein is 
  dimeric as assessed by multiwavelength static light scattering 
(measured mol wt = 148.2 ± 0.2 kD compared with 71.9 kD 
for the monomer; unpublished data), which is the expected 
  molecular organization of full-length FRLα. When expressed 
in macrophages, mini-FRLα–GFP is located in the cytoplasm 
of transfected cells (Fig. 2, E and F).
In the crystal structure of the DAD–DID complex from 
mDia1, the DAD forms an amphipathic helix with its hydro-
phobic face contacting the DID. Mutation of conserved residues 
on the hydrophobic face signifi   cantly decreases DAD–DID 
 affi  nity, and the mutation of hydrophilic residues on the solvent 
exposed face has little effect on this interaction (Lammers et al., 
2005; Otomo et al., 2005; Rose et al., 2005). With mini-FRLα, 
the mutation of any one of the conserved hydrophobic residues 
I1058, I1059, or L1062 on the hydrophobic face of the analo-
gous predicted helix results in plasma membrane localization 
of the protein (Fig. 2, G and H). In contrast, the mutation of 
  residues G1053 or E1056 on the hydrophilic face has no ef-
fect on localization (Fig. 2, G and H). Furthermore, the FRLα 
Figure 1.  The N terminus of FRL𝗂 negatively 
regulates actin assembly activity of the 
  C-terminal FH2 domain. (A) Schematic dia-
grams of FRLα and mDia1 constructs used in 
this study. (B) Interaction between the N and 
C termini of FRLα. 3 μM GST-tagged   N-terminal 
proteins were immobilized on glutathione–
Sepharose beads and used to pull down 3 μM 
C-terminal constructs. Puriﬁ   ed proteins are 
shown in lanes 2, 3, 6, and 9. Unbound pro-
teins in the ﬂ  ow through (FT) and proteins re-
maining on the beads after ﬁ  ve washes (B) are 
shown for each experiment. GST–N terminus 
was used to pull down wild-type C terminus 
(lanes 4 and 5) or C terminus L1062D contain-
ing a point mutation in the DAD domain (lanes 
7 and 8). GST–N terminus T126D (Cdc42-
binding mutant) was used to pull down wild-
type C terminus (lanes 10 and 11). For each 
experiment, the volumes loaded on the SDS-
PAGE gel were adjusted to equalize protein 
concentrations in the ﬂ  ow through and bead 
lanes. Gels are stained with Coomassie blue. 
(C) Similar to B except that the MBP-tagged 
wild-type C terminus (lane 2) or mutant C termi-
nus (lane 6) was immobilized on amylose resin 
and used to pull down GST–N terminus (lane 3). 
Flow through and bead samples from the wild-
type C-terminal pull down (lanes 4 and 5) or 
the mutant C-terminal pull down (lanes 7 and 8) 
are shown. (D) Dose-dependent inhibition of 
the actin assembly activity of 200 nM FRLα C 
terminus in the presence of the N terminus 
monitored by the increase in ﬂ  uorescence of 
4 μM pyrene-actin (5% labeled) upon incorpo-
ration into ﬁ   laments. (E) Maximum actin as-
sembly rate versus the concentration of N 
terminus. (F) Effect of the L1062D DAD motif 
mutation on the ability of 400 nM N terminus 
to inhibit 4 μM actin assembly (5% pyrene la-
beled) by 400 nM wild-type or mutant C termi-
nus. Note that mutant C terminus alone or 
mutant C terminus + N terminus curves over-
lap signiﬁ  cantly.JCB • VOLUME 174 • NUMBER 5 • 2006  704
N   terminus is cytoplasmic in cells coexpressing the DAD-
  containing C-terminal 100 residues of the protein but is mem-
brane   localized in cells coexpressing an L1062D mutant C 
terminus (Fig. S1, available at http://www.jcb.org/ cgi/content/
full/jcb.200605006/DC1). These results suggest that binding of 
the hydrophobic face of the amphipathic DAD helix is neces-
sary and suffi  cient to block membrane localization mediated by 
the FRLα N terminus. Our combined in vitro and in vivo data 
show that the interactions between the N and C termini are mu-
tually autoinhibitory, with the N terminus blocking the actin as-
sembly activity of the FH2 domain and the C terminus blocking 
the plasma membrane localization activity of the N terminus.
Cdc42 relieves FRL𝗂 autoinhibition in vitro 
and in vivo
We next sought to determine whether Rho GTPases could re-
lieve the autoinhibition of FRLα. Previously reported pull-down 
assays indicated that an N-terminal fragment of FRLα can 
 specifi  cally associate with Rac1 in a nucleotide-independent 
manner (Yayoshi-Yamamoto et al., 2000). However, we could 
not detect an interaction between recombinant Cdc42 or Rac1 
loaded with a GTP analogue, β,γ-imidoguanosine 5′-triphos-
phate (GMPPNP), and GST-tagged FRLα N terminus using 
similar assays (unpublished data). Unexpectedly, high concen-
trations of Cdc42-GMPPNP can relieve N-terminal inhibition 
of the FRLα FH2 domain (Fig. 3 A). The Cdc42 effect is dose 
dependent and saturates at  400 μM GTPase, a concentration 
that slightly decreases the activity of the isolated C terminus 
(Fig. 3, A and D). Under these conditions, although Cdc42-
GMPPNP exhibits low potency, it essentially fully relieves inhi-
bition by the N terminus. Cdc42-GDP is a much weaker activator 
compared with Cdc42-GMPPNP (Fig. 3, B and D). Rac1-
GMPPNP is unable to relieve the autoinhibition of FRLα actin 
assembly activity (Fig. 3 C) even at concentrations ( 400 μM) 
at which Cdc42-GMPPNP is maximally effective (Fig. 3 C). 
A V161D mutation in the mDia1 DID decreases Rho binding 
without affecting DAD binding (Otomo et al., 2005). The analo-
gous T126D mutation in the FRLα N terminus does not affect 
Figure 2. Autoinhibition regulates FRL𝗂 
  localization. Confocal images of RAW cells co-
expressing GFP fusion proteins and mRFP. The 
mRFP serves as an evenly distributed control 
ﬂ  uorophore. For these and all subsequent con-
focal images, the intensities for each channel 
have been normalized against the maximum 
value in the cell depicted in each image. As il-
lustrated in F, the degree of membrane local-
ization is not dependent on the total expression 
level of FRLα proteins. GFP fusion proteins are 
as follows: (A) full-length FRLα-GFP; (B) FRLα N 
terminus–GFP; (C) full-length FRLα-GFP contain-
ing an L1062D mutation in the DAD; (D) full-
length FRLα-GFP containing a V281E mutation 
in the DID; and (E) mini-FRLα–GFP consisting of 
the N terminus of FRLα fused directly to the 
DAD domain with an artiﬁ  cial  (Gly-Gly-Ser)2 
linker. (F) Membrane enrichment versus expres-
sion level for the indicated constructs. Each 
data point represents one transfected cell. As 
described in Materials and methods, for each 
cell expressing a given GFP fusion protein, 
  ratios were obtained for the GFP intensity at 
the plasma membrane against the GFP intensity 
in the cytosol. The ratios are plotted against 
the total GFP expression level in each cell 
  (expressed as the ﬂ   uorescence intensity per 
unit area). (G) Membrane enrichment versus 
expression level for the indicated constructs. 
Each data point represents one transfected 
cell. (H) Confocal images of cells coexpressing 
mRFP and the indicated mutant mini-FRLα–GFP 
fusion protein. The schematic protein diagram 
refers to the mini-FRLα construct depicted in 
Fig. 1 A and contains an asterisk signifying that 
the point mutations are all contained within the 
DAD region.AUTOINHIBITION REGULATES ACTIVITY/LOCALIZATION IN DRFS • SETH ET AL. 705
binding to the C terminus (Fig. 1 B) or inhibition of FH2-
  mediated actin assembly (Fig. 3 E) but blocks the ability of 
Cdc42-GMPPNP to relieve inhibition (Fig. 3 E).
When cotransfected with constitutively active Cdc42, 
both FRLα-GFP and mini-FRLα–GFP localize at the plasma 
membrane (Fig. 4, A, B, and I). The localization of FRLα is 
nucleotide and GTPase specifi  c, as the protein remains pri-
marily cytosolic in cells coexpressing dominant-negative Cdc42 
or constitutively active Rac1 or RhoA (Fig. 4, C–E and I). In 
all cases, expression of the different GTPase mutants was con-
fi  rmed by immunostaining (Fig. S2, available at http://www.
jcb.org/cgi/content/full/jcb.200605006/DC1). Like our GFP fu-
sions of FRLα, endogenous FRLα is primarily cytosolic in the 
absence of Cdc42. In cells transfected with constitutively ac-
tive Cdc42, endogenous FRLα becomes enriched at the plasma 
membrane (Fig. S2).
Because Cdc42 is membrane anchored through prenyl-
ation of its C-terminal CAAX motif, we tested whether Cdc42 
was directly recruiting FRLα to the plasma membrane of RAW 
cells. The T126D mutant FRLα N terminus, which is unrespon-
sive to Cdc42 in actin assembly assays, is enriched at the plasma 
membrane but to a lesser degree than the analogous wild-type 
fragment (Fig. 4, F and I). As with our other FRLα constructs, 
the degree of enrichment does not vary systematically with 
varying expression levels (Fig. 4 I). Thus, Cdc42 binding likely 
contributes to but is not necessary for membrane enrichment of 
the FRLα N terminus. However, signaling through Cdc42 does 
appear to be required for this membrane localization activity 
because coexpression of the FRLα N terminus with the GBD of 
the Wiskott-Aldrich syndrome protein (WASP; a reagent that at 
high levels should sequester the active GTPase) causes the 
FRLα fragment to be cytoplasmic (Figs. 4 G and S1). This relo-
cation to the cytoplasm is not observed when the FRLα N ter-
minus is coexpressed with a mutant WASP-GBD that cannot 
bind Cdc42 (Figs. 4 H and S1). These results suggest that mem-
brane localization activity of the FRLα N terminus derives, in 
part, from direct binding to Cdc42 and also from an interaction 
with some other membrane-associated factor that lies down-
stream of Cdc42.
Although our data suggest a direct interaction between 
Cdc42 and the N terminus of FRLα, we have been unsuc-
cessful in demonstrating a direct interaction in pull-down or 
 fl uorescence-based binding assays using bacterially expressed 
recombinant proteins (unpublished data). However, when co-
transfected into mammalian 293T cells, constitutively active 
Cdc42 and the wild-type FRLα N terminus can be coimmuno-
precipitated (Fig. 4 J, lanes a–c). The N terminus does not 
coimmunoprecipitate with constitutively active Rac1 or RhoA 
(Fig. 4 J, lanes g–i and j–l, respectively), suggesting speci  fi  city 
for Cdc42 over these other two Rho family members. One 
caveat here is that despite signifi  cant effort, the level of Rac 
expression was always lower than that of Cdc42 in these exper-
iments. However, along with the biochemistry and aforemen-
tioned localization data, these results do support a much greater 
role for Cdc42 than Rac in regulating FRLα. The T126D mutant 
N terminus does not coimmunoprecipitate with Cdc42, sug-
gesting that in vitro and in cells, the Cdc42 responsiveness of 
FRLα is mediated by the same set of interactions (Fig. 4 J, lanes 
Figure 3.  Active Cdc42 relieves the auto-
inhibition of FRL𝗂 actin assembly activity. 
Actin assembly assays were performed with 
4 μM actin (5% pyrene-labeled). (A) Effect on 
the inhibition of actin assembly by 200 nM 
C terminus in the presence of 400 nM N ter-
minus by the addition of the indicated amount 
of Cdc42-GMPPNP. (B) Similar to A except us-
ing Cdc42-GDP. (C) Similar to A except using 
Rac1-GMPPNP. (D) Actin assembly rate versus 
the concentration of Cdc42 based on curves 
in A and B. (E) Actin assembly by 200 nM 
C terminus in the presence of 1 μM wild-type 
N terminus or 1 μM T126D N terminus with or 
without 200 μM Cdc42-GMPPNP.JCB • VOLUME 174 • NUMBER 5 • 2006  706
d–f). Furthermore, full-length FRLα and mini- FRLα do not co-
immunoprecipitate with Cdc42 even though they localize at the 
plasma membrane when coexpressed with constitutively active 
Cdc42 (Fig. 4 J, lanes m–o and p–r, respectively). These results 
suggest that Cdc42 has higher affi  nity for the FRLα N terminus 
as compared with an autoinhibited FRLα molecule, which is 
consistent with the idea that Cdc42 must compete with the auto-
inhibitory interactions present in full-length or mini-FRLα.
Our in vitro and in vivo data suggest that FRLα is a direct 
effector of Cdc42 and that the interactions between FRLα and 
Cdc42 may be similar to those between mDia1 and Rho. Cdc42 
relieves the autoinhibition of FRLα actin assembly activity in 
vitro and relieves the autoinhibition of FRLα membrane local-
ization in macrophages. The affi  nity of Cdc42 for FRLα  appears 
to be weak, suggesting that Cdc42 may have to cooperate with 
other factors to regulate FRLα in vivo.
Figure 4.  Active Cdc42 relieves the autoinhibition of FRL𝗂 localization. (A and B) Confocal images of RAW cells coexpressing mRFP, constitutively 
active Cdc42, and full-length FRLα-GFP (A) or mini-FRLα–GFP (B). (C–E) Confocal images of RAW cells expressing mRFP, full-length FRLα-GFP, and domi-
nant-  negative Cdc42 (C), constitutively active Rac1 (D), or constitutively active RhoA (E). (F) Confocal images of a cell expressing mRFP and the FRLα 
N terminus T126D-GFP mutant. (G and H) Confocal images of cells coexpressing N terminus–GFP and an mRFP fusion of WASP-GBD (G) or a mutant 
WASP-GBD (H) that does not bind Cdc42. For each transfection, 1 μg FRL construct was cotransfected with 4 μg GBD construct. (I) Membrane enrich-
ment versus expression level for the indicated constructs. Each data point represents one transfected cell. (J) Coimmunoprecipitation experiments using 
lysates from 293T cells coexpressing myc-tagged Rho GTPase mutants and different FRLα-GFP constructs. Lysates were immunoprecipitated using anti-GFP 
or control IgG antibodies and blotted with anti-GFP or anti-myc antibodies. For each experiment (lanes a–c, d–f, g–i, j–l, m–o, and p–r), the lysate (starting 
  material) is shown in the ﬁ  rst lane followed by the material bound to control IgG beads or anti-GFP beads in the next two lanes. MW, molecular weight; 
SM, starting material.AUTOINHIBITION REGULATES ACTIVITY/LOCALIZATION IN DRFS • SETH ET AL. 707
Autoinhibitory control of mDia1 
intracellular localization
As in FRLα, a GFP fusion of the N terminus of mDia1(residues 
1–570) is localized at the plasma membrane (Fig. 5, A and F). 
Both full-length mDia1-GFP and mini-mDia1–GFP, analogous 
to our mini-FRLα construct, are cytoplasmic and are excluded 
from the nucleus of RAW cells (Fig. 5, B, C, and F). Thus, 
autoinhibition controls the localization of mDia1 in a manner 
analogous to FRLα. Also, like FRLα, the membrane localiza-
tion activity in the mDia1 N terminus has GTPase-dependent 
and -independent components. The V161D mutant N-terminal 
fragment of mDia1 (analogous to the aforementioned FRLα 
T126D mutant) is strongly defective in Rho binding (Otomo 
et al., 2005). This protein localizes to the plasma membrane in 
macrophages but to a lesser degree than the wild-type N termi-
nus (Fig. 5, D and F). Interestingly, the degree of membrane en-
richment of this protein decreases as expression level increases 
(Fig. 5, D and F), suggesting that the GTPase-  independent 
membrane interaction is saturable. A nearly identical behavior 
is also observed for a fragment of the mDia1 N terminus lack-
ing the G region entirely (Fig. 5, E and F; mDia1_∆G_N-term), 
which also is severely impaired in Rho binding (Otomo et al., 
2005; Rose et al., 2005). Analogous fragments of FRLα are 
not expressed in bacteria (in contrast to mDia1_∆G_N-term, 
which expresses well; unpublished data), are expressed only 
weakly and inconsistently in macrophages, and were not ana-
lyzed in detail. Together, our data suggest that for both FRLα 
and mDia1, plasma membrane localization of the N terminus is 
mediated by GTPase-dependent and -independent interactions 
and that these are controlled by autoinhibitory contacts within 
the formins.
FRL𝗂 is required for Fc-𝗄 receptor–
mediated phagocytosis and is recruited 
to the phagocytic cup by Cdc42
We next sought to determine whether FRLα is involved in 
Fc-γ receptor–mediated phagocytosis. This process is Cdc42 
dependent and requires extensive actin rearrangement at the 
cell surface of macrophages (Caron and Hall, 1998). Using two 
different sets of siRNAs directed against FRLα, we achieved 
signifi  cant knockdown of endogenous FRLα in RAW macro-
phages (Fig. 6 A). These reduced Fc-γ receptor–mediated 
phagocytosis of IgG-opsonized RBCs by 45 ± 4 and 29 ± 2%, 
respectively, compared with cells expressing control siRNAs 
Figure 5.  Autoinhibition controls localization of the Rho-regulated DRF mDia1. (A–D) Confocal images of RAW cells coexpressing mRFP and mDia1 
N terminus–GFP (A), full-length mDia1-GFP (B), mini-mDia1–GFP (C), or mDia1 V161D N terminus–GFP (D). Three different cells are shown to illustrate the 
  different patterns observed for this construct. The GFP fusion is localized at the plasma membrane in the ﬁ  rst cell (top) and in the cytosol of the third cell 
  (bottom). The second cell (middle) has an intermediate distribution between membrane and cytosol. (E) mDia1 ∆G–N terminus–GFP. Three different cells 
are shown to illustrate the different localization patterns observed with this construct. (F) Membrane enrichment versus expression level for the indicated 
constructs. Each data point represents one transfected cell.JCB • VOLUME 174 • NUMBER 5 • 2006  708
(Fig. 6 B). Overall cell appearance, adhesion, and fi  lamentous 
actin content judged by phalloidin staining are all normal in 
the siRNA-treated cells (Fig. S3 A, available at http://www.jcb.
org/cgi/content/full/jcb.200605006/DC1). Moreover, comple-
ment receptor-mediated phagocytosis, a process that proceeds 
through a Rho–mDia1 pathway (Colucci-Guyon et al., 2005), 
is also unaffected by siRNA treatment (Fig. S3 B). These re-
sults demonstrate that the knockdown of FRLα does not lead to 
generalized cytoskeletal defects in RAW cells and establish an 
important role for FRLα specifi  cally in Fc-γ receptor– mediated 
phagocytosis.
We used time-lapse microscopy to analyze phagocytic 
events in live RAW macrophages incubated with IgG-opsonized 
RBCs at 37°C. Under our assay conditions, macrophages read-
ily phagocytose the RBCs with a time course of  90 s from 
cell–cell contact to complete RBC internalization as judged by 
light microscopy. For RBCs that encounter macrophages from 
the side, the extension of macrophage pseudopods around the 
RBC is readily observable in fl  uorescently labeled cells. The 
pseudopods eventually meet at the top of the RBC and fuse to 
close the phagosome, which is then internalized into the main 
cell body.
Figure 6.  Cdc42 recruits FRL𝗂 to the phagocytic cup during Fc-𝗄 receptor–mediated phagocytosis. (A) Western blot of lysates prepared from cells trans-
fected with siRNAs directed against FRLα or GFP (control) and probed with anti-FRLα or anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH; loading 
control) antibodies. (B) Phagocytic index (number of RBCs/100 macrophages) of siRNA-transfected RAW macrophages. Experiments were performed in 
duplicate and repeated three times. Data are the means based on counting at least 300 macrophages per experiment. (C) FRLα-GFP–expressing cell under-
going Fc-γ receptor–mediated phagocytosis. The zero time point is a reference for when the phagosome closes around the RBC being engulfed. The top 
panels are pseudocolored to represent the GFP/mRFP ratio at each pixel in the cell. Low ratios are represented by blue or cool colors, whereas higher ratios 
are represented by increasingly red or warmer colors. Bottom panels are the corresponding DIC images for each time point. The ingested RBCs are indi-
cated by arrows. The insets depict additional magniﬁ  cation of the phagocytic cup. (D) Time course of formin accumulation during Fc-γ receptor–mediated 
phagocytosis. n indicates the number of phagocytic events analyzed for each construct. For each time point, the GFP/mRFP ratio at the cell surface in 
  contact with the RBC (Rp) was divided by the ratio in the cell cytoplasm (Rc). Error bars represent SEM.AUTOINHIBITION REGULATES ACTIVITY/LOCALIZATION IN DRFS • SETH ET AL. 709
In cells coexpressing FRLα-GFP and mRFP, we used 
ratiometric imaging to determine specifi   c sites of FRLα 
  accumulation. During phagocytosis, FRLα-GFP accumulates in 
the developing phagocytic cup and appears to concentrate at the 
tips of the extending pseudopods (Fig. 6 C and Videos 1–3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200605006/DC1). 
FRLα-GFP accumulation is maximal immediately before pseu-
dopod fusion, which we set as a reference time point to compare 
multiple phagocytic events, and rapidly dissipates as the RBC is 
internalized (Fig. 6, C and D). This spatial and temporal pattern 
is reproducibly observed in different transfected cells; additional 
phagocytic events are shown in Fig. S4. A control GFP construct 
fused to the C-terminal 101 residues of FRLα does not accu-
mulate at the phagocytic cup (Fig. 6 D). Consistent with previ-
ous fi  ndings that Rho is not involved in Fc-γ   receptor– mediated 
phagocytosis (Caron and Hall, 1998), mDia1-GFP does not 
localize to the cup during this process (Fig. 6 D). The T126D 
mutant of FRLα shows a consistent modest increase in local-
ization at the cup relative to mDia1 and the FRL C terminus, 
but its enrichment does not change appreciably over the course 
of internalization (Fig. 6 D). This enrichment is likely caused 
by the ability of the T126D mutant N terminus to interact with 
membranes (Fig. 4, F and I), which accumulate at the cup as a 
result of its topology. Importantly, the wild-type protein shows 
much different behavior, with a greater degree of accumulation 
and substantial changes over the course of the process, suggest-
ing recruitment to the cup by an active mechanism.
Active Cdc42 has also been shown to accumulate tran-
siently at the extending pseudopod tips of the phagocytic cup 
(Hoppe and Swanson, 2004). We monitored the localization of 
active Cdc42 during phagocytosis using the WASP-GBD fused 
to GFP, a reagent with high (19 nM) affi  nity for active Cdc42 
(Kim et al., 2000b; Cannon et al., 2001; Labno et al., 2003; Seth 
et al., 2003). We note that at high levels of expression, this re-
agent blocked phagocytosis (unpublished data), but, at lower 
levels, it had no effect on phagocytic effi  ciency, and we could 
use it to visualize active Cdc42 during this process. As a con-
trol, we used a mutant GBD-GFP construct that is unable to 
bind Cdc42. We fi  nd that Cdc42, like FRLα, is recruited tran-
siently to the phagocytic cup and that its accumulation peaks 
immediately before pseudopod fusion (Fig. 7, A and B; and 
Videos 4 and 5, available at http://www.jcb.org/cgi/content/full/
jcb.200605006/DC1). The similarities in timing and localiza-
tion of active Cdc42 and FRLα support the idea that FRLα 
function during phagocytosis is linked to Cdc42 signaling.
Discussion
Autoinhibition of DRF actin 
assembly activity
We have generated N-terminal fragments of FRLα based on 
  recent crystal structures of the mDia1 N terminus (Otomo et al., 
2005; Rose et al., 2005) to investigate the mechanisms of auto-
inhibition and activation in FRLα. Based on fragmented DID 
constructs, earlier work suggested that FRLα may bind Rac 
(Yayoshi-Yamamoto et al., 2000). However, using constructs 
containing intact structural domains that are biochemically well 
behaved, we now show that FRLα is a Cdc42-specifi  c   effector. 
Figure 7.  Recruitment of active Cdc42 to the phagocytic 
cup during Fc-𝗄 receptor–mediated phagocytosis. (A) GBD-
GFP–expressing cell undergoing Fc-γ receptor–mediated 
phagocytosis. Cells were transfected with plasmids encoding 
mRFP and the indicated GBD-GFP construct. 2.5 μg of each 
plasmid (5 μg of total DNA) was used for each transfection. 
As in Fig. 6 C, the GFP/mRFP ratio is pseudocolored in the 
top panel to reﬂ   ect the relative accumulation of GBD-GFP 
over mRFP. Localization of the GBD-GFP protein reﬂ  ects the 
distribution of Cdc42-GTP during phagocytosis. Arrows in 
the bottom panels of DIC images indicate the ingested RBCs. 
  Insets depict additional magniﬁ  cations of the phagocytic cup. 
(B) Time course of active Cdc42 accumulation during Fc-γ 
receptor–mediated phagocytosis. Multiple phagocytic events 
were analyzed as in Fig. 6 B in cells expressing mRFP and 
GBD-GFP or the mutant GBD-GFP (as a negative control). 
  Error bars represent SEM.JCB • VOLUME 174 • NUMBER 5 • 2006  710
Several lines of evidence support this assertion. Cdc42 is able 
to relieve the autoinhibition of FH2-mediated actin assembly 
by the wild-type N terminus but not by the T126D mutant 
N   terminus. Mutation of the analogous residue in mDia1 pre-
vents direct Rho binding and Rho-mediated activation (Otomo 
et al., 2005). Furthermore, the wild-type FRLα N terminus co-
immunoprecipitates with active Cdc42 from cell lysates, but the 
point mutant does not. In addition, the timing and localization 
of Cdc42 and wild-type FRLα are largely coincident during 
phagocytosis, and the recruitment of FRLα to the phagocytic 
cup is blocked by the T126D mutation. Similar biochemical, 
coimmunoprecipitation, and localization assays fail to show a 
link between Rac1 activity and FRLα function. However, the 
interaction between Cdc42 and FRLα appears to be of low af-
fi  nity, and the interaction between them may be modulated by 
cellular factors.
Autoinhibition of DRF localization: 
a membrane factor X?
The functional signifi  cance of the N terminus of DRFs has 
been thought to be limited to mediating the autoinhibition of the 
C terminus (Evangelista et al., 2003; Wallar and Alberts, 2003; 
Higgs, 2005). We now show for the DRFs FRLα and mDia1 that 
interactions between the N and C termini mediate the mutual 
autoinhibition of DRF localization and biochemical   activity. 
The membrane localization activity of the DRF N termini de-
rives, in part, from interactions with Rho GTPases. However, 
our results suggest that the N termini can also bind an additional 
membrane-associated factor. This factor binds the N termini 
competitively with the DAD and, thus, should contribute to 
DRF activation. Depending on the structural details of the inter-
action, the factor may act cooperatively with GTPases to drive 
DRF membrane localization and activation.
Coordinated cytoskeletal remodeling during 
Fc-𝗄 receptor–mediated phagocytosis
Cdc42 plays an essential role in Fc-γ receptor–mediated phago-
cytosis (Caron and Hall, 1998). Formins have not previously 
been implicated in this process, although mDia1 has recently 
been shown to be involved in complement-mediated phago-
cytosis, a Rho-mediated process (Colucci-Guyon et al., 2005). Our 
identifi  cation of FRLα as a Cdc42 effector led us to test whether 
this macrophage-enriched DRF is involved in Fc-γ receptor–
mediated phagocytosis. Two previous studies on Fc receptor–
mediated phagocytosis reported that dominant-  negative Cdc42 
inhibits phagocytosis by  40–70% (Caron and Hall, 1998; 
Massol et al., 1998), which is similar to what we observe for our 
strongest FRLα knockdown (45%). The consistent degree of in-
hibition by dominant-negative Cdc42 and FRLα RNAi suggests 
that FRLα is an important effector of Cdc42-mediated signaling 
during Fc-γ receptor–mediated phagocytosis.
It is useful to distinguish three phases of Fc-γ receptor–
mediated phagocytosis: pseudopod extension, pseudopod fu-
sion, and particle internalization (Castellano et al., 2001; May 
and Machesky, 2001; Swanson and Hoppe, 2004). Time-lapse 
imaging shows that fl   uorescently labeled actin accumulates 
at the base and extending pseudopods of the phagocytic cup 
(Araki et al., 2003; Scott et al., 2005). At closure, actin forms a 
sphere around the phagosome (Scott et al., 2005). After closure, 
actin dissipates from the phagosome starting at the base, result-
ing in a short-lived actin cap structure at the top of the phago-
some (Scott et al., 2005). The actin architectures at each phase 
of phagocytosis and the signaling pathways that control their 
formation have yet to be determined.
Recent studies have started to defi  ne the spatio-temporal 
patterns and functional roles of different actin regulatory pro-
teins during Fc-γ receptor–mediated phagocytosis, focusing 
mostly on Cdc42 and Rac (Caron and Hall, 1998; Massol et al., 
1998; Castellano et al., 1999; Castellano and Chavrier, 2000; 
Hoppe and Swanson, 2004). The model that has emerged from 
these studies suggests that active Cdc42 localizes primarily at 
the tips of the extending pseudopods, mediating their extension 
and dissipating rapidly after their fusion. In contrast, active 
Rac1 is localized at the base and throughout the pseudopods 
during extension and then concentrates at the base to control 
  fusion and internalization. Thus, Cdc42 and Rac likely play 
  different roles during Fc-γ receptor–mediated phagocytosis.
In contrast to the Rho GTPases, the actions of downstream 
signaling molecules during phagocytosis have been studied less 
extensively. WASP family proteins are important for Arp2/3 com-
plex activation during cell migration (Pollard and Borisy, 2003), 
and static images reveal that the WASP and Arp2/3 complex are 
recruited to the phagocytic cup (May et al., 2000;   Coppolino 
et al., 2001). However, the detailed spatio-temporal patterns of 
these molecules during phagocytosis have not been reported.
Fc-γ receptor–mediated phagocytosis represents one of the 
fi  rst isolated cytoskeletal systems in higher eukaryotes in which 
both Arp2/3 (May et al., 2000) and formins (this study) have 
essential functions. Why might two different actin nucleation 
machines be required for Fc-γ phagocytosis? Although both the 
Arp2/3 complex and FRLα can nucleate actin fi  laments, there 
are important differences in their resulting actin networks. 
Arp2/3 networks are branched and sensitive to capping proteins, 
and, therefore, the behavior of the Arp2/3 network depends on 
the balance of capping and nucleation. FRLα-generated fi  la-
ments are unbranched and resistant to capping proteins. Based 
on its linkage to Cdc42, FRLα function may be important pri-
marily for pseudopod extension, whereas the Arp2/3 complex 
may be required for the other phases of phagocytosis. In addi-
tion to nucleating new fi  laments, the FRLα FH2 domain can 
also sever actin fi  laments (Harris et al., 2004). This activity 
could lead to an increase in ATP-capped fi  lament ends, which 
appear to be preferential sites of Arp2/3-mediated branching 
(Ichetovkin et al., 2002). Indeed, FRLα may not serve a nucle-
ation function during phagocytosis at all but rather may facilitate 
pseudopod extension by functioning as an anticapping or sever-
ing protein to modify the Arp2/3 actin network. Currently, the 
specifi  c biochemical and biological roles of FRLα and Arp2/3 
complex during Fc-γ receptor–mediated phagocytosis remain 
elusive. Understanding the detailed molecular mechanisms of 
phagocytosis will shed light on this essential function of the im-
mune system and will help determine the relative contributions 
of different actin regulatory elements to cytoskeletal dynamics 
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Materials and methods
Constructs
Full-length FRLα (residues 1–1,094), the FRLα N terminus (residues 1–450), 
the FRLα C terminus (residues 612–1,094), and the FRLα ∆FH2–C terminus 
(residues 994–1,094) were cloned into pET vectors containing N-terminal 
tobacco etch virus protease-cleavable GST or MBP afﬁ   nity tags. FRLα 
cDNA was provided by T. Watanabe (Kyushu University, Fukuoka, Japan). 
Full-length mDia1 (resides 1–1,255), the mDia1 N terminus (residues 
1–570), and the mDia1 ∆G–N terminus (residues 131–570) were cloned 
by PCR. All FRLα and mDia1 constructs were cloned into a modiﬁ  ed pCMV-
Script vector containing C-terminal EGFP or mRFP. Template cDNA for 
mRFP was provided by R.Y. Tsien (University of California, San Diego, San 
Diego, CA). Mini-FRLα (residues 1–536 and 994–1,094 tethered by a 
GGSGGS linker) and mini-mDia1 (residues 1–457 and 1,168–1,255 teth-
ered by a GGSGGS linker) were generated using overlap extension PCR. 
Myc-tagged GTPase constructs were provided by M.H. Cobb (University of 
Texas Southwestern, Dallas, TX). The WASP-GBD comprises residues 230–
288 of the human protein. The WASP-GBD mutant was generated by 
scrambling the amino acid sequence of the internal Cdc42/Rac interactive 
binding motif (I  G  A  P  S  G  F  K  H  V  S  H  V  G  W  D   mutated to K  W  D  V  P  I  H  H  G  G  F  G  A  S  V  S  ), 
which is necessary for high afﬁ  nity interactions with Cdc42 (Rudolph 
et al., 1998).
The following siRNA oligonucleotides were used for RNAi experi-
ments: FRL2614 sense (C  A  G  A  C  G  U  U  G  U  U  G  C  A  C  U  A  C  U  T  T  ), FRL2614 
  antisense (A  G  U  A  G  U  G  C  A  A  C  A  A  C  G  U  C  U  G  T  T  ), GFP sense (G  C  A  G  A  A  G  A  A-
C  G  G  C  A  U  C  A  A  G  T  T  ), and GFP antisense (C  U  U  G  A  U  G  C  C  G  U  U  C  U  U  C  U  G  C  T  T  ). 
The second set of FRL siRNAs, which was purchased from Dharmacon, was 
a pool of four duplexes that did not overlap with the sequence targeted by 
the ﬁ  rst siRNA duplex.
Bacterial expression and protein puriﬁ  cation
All proteins were expressed in the Escherichia coli strain BL21(DE3). FRLα 
N-terminal constructs were expressed as GST fusion proteins, whereas 
C-terminal constructs were expressed as MBP fusions. N-terminal constructs 
were puriﬁ  ed using glutathione–Sepharose beads (GE Healthcare), anion 
exchange chromatography, and gel ﬁ  ltration. C-terminal constructs were 
puriﬁ   ed by cation exchange chromatography and gel ﬁ  ltration.  Before 
some assays, the afﬁ  nity tags were cleaved using tobacco etch virus prote-
ase, and the tag-free proteins were puriﬁ  ed either with anion or cation ex-
change chromatography. Cdc42 (residues 1–179) was prepared and 
loaded with GMPPNP as previously described (Abdul-Manan et al., 1999; 
Kim et al., 2000a). Actin was puriﬁ  ed from rabbit skeletal muscle and 
  labeled with pyrene as described previously (Pollard and Cooper, 1984).
Biochemical assays
Pull-down experiments. 600 pmol GST-FRLα N terminus was loaded onto 
glutathione–Sepharose beads (GE Healthcare) and incubated with 600 
pmol FRLα C terminus in 200 μl of binding buffer (20 mM Tris, pH 8.0, 
100 mM NaCl, and 1 mM DTT). Beads were washed three times with 
200 μl of the binding buffer containing 0.1% Triton X-100, washed twice 
with 200 μl of the binding buffer without detergent, and analyzed by SDS-
PAGE and Coomassie blue staining. The same protocol was also per-
formed with 600 pmol MBP–C terminus on amylose resin (New England 
Biolabs, Inc.) incubated with 600 pmol of GST–N terminus.
Actin assembly assays. Experiments were performed as described 
previously (Higgs et al., 1999). Reactions contained 4 μM actin (5% 
  pyrene labeled), 10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM EGTA, 
and 1 mM MgCl2. Pyrene ﬂ  uorescence (λex = 365 nm and λem = 407 nm) 
was recorded over time to monitor actin assembly.
Cell culture and transfection
RAW 264.7 cells were purchased from the American Type Culture Collec-
tion and maintained in DME with 10% FBS and 1 mM sodium pyruvate 
(  Invitrogen). 10
6 cells were transfected with 5 μg DNA using LipofectAMINE 
2000 (Invitrogen). For siRNA transfection, 2 × 10
5 cells were transfected 
with siRNAs using 1.5 μl siQuest reagent (Mirus Bio Corporation) and 
250 nM siRNAs. Under these conditions, nearly 100% of RAW cells were 
transfected by siRNAs as judged by experiments using LabelIT Fluorescent 
RNA delivery controls (Mirus Bio Corporation). To determine the efﬁ  ciency 
of FRLα knockdown, cell lysates were prepared 48 h after transfection. 
Western blots were performed using anti-FRLα antibodies provided by 
H.N. Higgs (Dartmouth College, Hanover, NH).
HEK293T cells were maintained in 10% calf serum (American 
Type Culture Collection) and 1 mM penicillin/streptomycin (Invitrogen). 
For coimmunoprecipitation, 10
6 cells plated in 10-cm dishes were trans-
fected with 10 μg DNA using the calcium phosphate precipitation method.
Coimmunoprecipitation
HEK293T cells were cotransfected with expression vectors for each formin-
GFP and myc-GTPase construct. 36 h after transfection, cell lysates were 
prepared in lysis buffer (20 mM Tris, pH 7.4, 100 mM NaCl, 1 mM DTT, 
1 mM MgCl2, 0.2% NP-40, 1 mM PMSF, 1 mM benzamidine, 1 μg/ml leu-
peptin, 1 μg/ml antipain, 0.5 μg/ml pepstatin, 20 mM NaF, and 0.5 mM 
NaVO3). The cleared lysate was incubated with anti-GFP antibody (Invit-
rogen) for 1 h at 4°C. Immune complexes were precipitated with UltraLink 
immobilized   protein A/G beads (Pierce Chemical Co.) and analyzed by 
Western blotting.
Confocal microscopy
24 h after transfection, cells were replated onto 12-mm glass coverslips 
(Fisher Scientiﬁ  c), allowed to adhere for 6–8 h, and were ﬁ  xed. Imaging 
was performed on a laser scanning microscope (LSM510 META; Carl 
Zeiss MicroImaging, Inc.) using a 63× oil immersion objective (Carl Zeiss 
MicroImaging, Inc.). Images were analyzed using Slidebook software 
  (Intelligent Imaging Innovations). Membrane and cytosolic intensities were 
determined by calculating the mean ﬂ  uorescence in masks placed either at 
the membrane or in the cytoplasm. The expression level was expressed as 
the sum of the ﬂ  uorescence intensity across a given confocal plane divided 
by the cross-sectional area.
Phagocytosis assays for live cell imaging
Image acquisition. 24 h after transfection, cells were replated onto 35-mm 
glass-bottom dishes and allowed to adhere for 6–8 h. For imaging, cells 
were incubated at 37°C on a heated stage connected to a humidiﬁ  er 
  module and covered with an optically clear foil cover (Carl Zeiss Micro-
Imaging, Inc.). To start phagocytosis, 1 ml of 50-fold diluted opsonized 
RBCs prepared as described previously (Greenberg et al., 1990) was 
added dropwise to the macrophages. For each imaging run, 61 time 
points were collected. For each time point, a four-plane z stack of GFP and 
mRFP ﬂ  uorescent images spaced 1.5 μm apart was acquired along with 
one differential interference contrast (DIC) image (50-ms exposure). A total 
of nine images per time point was collected at maximum speed, which, on 
our   system, resulted in one time point per 13.7 s.
Imaging was performed using a 63× oil immersion objective (Carl 
Zeiss MicroImaging, Inc.) on an inverted microscope (Axiovert 200M; Carl 
Zeiss MicroImaging, Inc.) equipped with a 75-W Xenon lamp and CCD 
camera (Sensicam; PCO Computer Optics). Fluorescence images were 
  acquired using FITC and Cy3 ﬁ   lter sets (Chroma Technology Corp.), 
200-ms exposure times, 2 × 2 binning, and a 10% neural density ﬁ  lter.
Image analysis. For each phagocytic event, the optimal plane 
(where the phagoyctic cup was in best focus) was determined at each time 
point. These planes were stitched together to create a 2D time-lapse series. 
For each event, the time point at which pseudopod fusion occurred, as 
seen in the ﬂ  uorescent images, was set as the zero time reference. Only 
events in which the macrophage and RBC could be observed 8 time points 
before fusion and 23 time points after were further analyzed. Thus, for 
each event we have analyzed 32 time points, which is sufﬁ  cient for com-
plete analysis of the dynamics that we observe.
To analyze fusion protein accumulation during phagocytosis, we av-
eraged the GFP/mRFP ratio at the site of phagocytosis (Rp) and normalized 
it to the GFP/mRFP ratio in the cytoplasm (Rc) in a manner similar to previ-
ously described methods (Hoppe and Swanson, 2004). Rp was calculated 
by creating a mask around the region of contact between the macrophage 
and the RBC. An Rc mask, which was placed in the cytoplasm, was also 
created. For each pixel in each mask at each time point, we calculated the 
ratio of GFP intensity to mRFP intensity. We then averaged the ratios for 
each mask to generate the GFP/mRFP ratio at the site of phagocytosis or 
in the cytoplasm.
Phagocytosis assays for siRNA-transfected cells
24 h after transfection, RAW cells were replated onto 12-mm glass cover-
slips. 48 h after transfection, cells were washed and returned to the 37°C 
incubator in 0.2 ml of buffer with divalents (20 mM Hepes, pH 7.4, 125 
mM NaCl, 5 mM KCl, 5 mM glucose, 10 mM NaHCO3, 1 mM KH2PO4, 
1 mM MgCl2, and 1 mM CaCl2). After 1 h, 20 μl of 10-fold diluted 
  opsonized RBCs were added. For complement phagocytosis, cells were 
treated with 100 nM PMA 30 min before the addition of RBCs. After 1 h, 
cells were washed, incubated in distilled water to lyse extracellular RBCs, 
and ﬁ  xed. Cells were permeabilized with PSG buffer (PBS, 0.01%   saponin, JCB • VOLUME 174 • NUMBER 5 • 2006  712
0.25% gelatin, and 0.02% NaN3). Intracellular RBCs were stained with 
1:200 diluted FITC-conjugated anti–rabbit antibodies (Jackson Immuno-
Research Laboratories). Imaging was performed on an inverted micro-
scope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) using a 63× oil 
immersion objective (Carl Zeiss MicroImaging, Inc.). The number of inter-
nalized RBCs was counted using the FITC ﬂ   uorescence signal, and the 
number of macrophages was counted using cellular autoﬂ  uorescence. For 
complement phagocytosis, internalized RBCs were counted using DIC. 
Each experiment was performed in duplicate, and a minimum of 300 macro-
phages was counted for every condition.
Online supplemental material
Table S1 provides the mean GFPm/GFPc ratios for all constructs and condi-
tions tested. Fig. S1 shows that membrane localization of the FRLα N terminus 
is inhibited by DAD binding in trans. Fig. S2 shows the localization of en-
dogenous FRLα and expression of myc-tagged Rho GTPase mutants in RAW 
cells. Fig. S3 shows the characterization of cells treated with FRLα siRNA, 
and Fig. S4 shows additional images of FRLα recruitment to the phagocytic 
cup. Videos 1 and 2 are DIC and ﬂ  uorescence time lapses, respectively, 
of FRLα-GFP–expressing macrophages undergoing Fc-γ   receptor–mediated 
phagocytosis. Video 3 shows a magniﬁ  ed phagocytic cup from Video 2. 
Videos 4 and 5 are DIC and ﬂ   uorescence time lapses, respectively, of 
GBD-GFP–expressing macrophages undergoing Fc-γ   receptor–mediated 
phagocytosis. Online supplemental material is available at http://www.
jcb.org/cgi/content/full/jcb.200605006/DC1.
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